Galantamine Hydrobromide | Suppliers | Impurities | Impurity Standards| PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Galantamine Hydrobromide
Others

PharmaCompass Sponsored Ads

Contact Supplier

Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Contact Supplier

Suanfarma, at the Core of a Better Life.

Contact Supplier

xyz-pharma-m-2025-04-14

Contact Supplier

Galantamine Hydrobromide

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

30 API Suppliers, 15 USDMF, 8 CEP/COS, 4 JDMF, 2 EU WC, 5 KDMF, 6 NDC API, 14 Listed Suppliers, $ API Reference Price

30 API Suppliers
15 USDMF
8 CEP/COS
4 JDMF
2 EU WC
5 KDMF
6 NDC API
14 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

3 Drugs in Development

3 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

246 FDF Dossiers, 71 FDA Orange Book, 110 Europe, 15 Canada, 24 Australia, 9 South Africa, 17 Listed Dossiers

246 FDF Dossiers
71 FDA Orange Book
110 Europe
15 Canada
24 Australia
9 South Africa
17 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 12MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 4MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 8MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, EXTENDED RELEASE;ORAL - EQ 16MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, EXTENDED RELEASE;ORAL - EQ 24MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, EXTENDED RELEASE;ORAL - EQ 8MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 12MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 4MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 8MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
CAPSULE, EXTENDED RELEASE;ORAL - EQ 16MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
CAPSULE, EXTENDED RELEASE;ORAL - EQ 24MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
CAPSULE, EXTENDED RELEASE;ORAL - EQ 8MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem, 2 Rochem International Inc, 18 SPI Pharma, 11 DKSH, 6 Faran Shimi Pharmaceutical, 5 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 6 Gangwal Healthcare, 5 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 1 Pramukh Pharmachem, 1 Zeal MediPharma, 4 ACG Worldwide, 7 Actylis, 1 Aeon Procare, 2 Alcedo Pharmachem, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 30 BASF, 1 Clariant, 11 Corel Pharma Chem, 6 DFE Pharma, 2 Finar, 11 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 37 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 15 Microlex e.U, 1 Nanjing Bold Chemical, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 3 Novo Excipients, 5 Pharmatrans-Sanaq, 6 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 19 Roquette, 14 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 3 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 3 Vasa Pharmachem, 2 Vertellus

EXCIPIENTS BY APPLICATIONS

87 Fillers, Diluents & Binders, 53 Coating Systems & Additives, 37 Direct Compression, 35 Disintegrants & Superdisintegrants, 34 Thickeners and Stabilizers, 32 Controlled & Modified Release, 30 Granulation, 26 Solubilizers, 24 Taste Masking, 20 Lubricants & Glidants, 19 Chewable & Orodispersible Aids, 18 Film Formers & Plasticizers, 16 Co-Processed Excipients, 15 Parenteral, 15 Topical, 9 Empty Capsules, 8 Emulsifying Agents, 6 Rheology Modifiers, 5 Surfactant & Foaming Agents, 5 API Stability Enhancers, 5 Coloring Agents, 4 Vegetarian Capsules

87 Fillers, Diluents & Binders
53 Coating Systems & Additives
37 Direct Compression
35 Disintegrants & Superdisintegrants
34 Thickeners and Stabilizers
32 Controlled & Modified Release
30 Granulation
26 Solubilizers
24 Taste Masking
20 Lubricants & Glidants
19 Chewable & Orodispersible Aids
18 Film Formers & Plasticizers
16 Co-Processed Excipients
15 Parenteral
15 Topical
9 Empty Capsules
8 Emulsifying Agents
6 Rheology Modifiers
5 Surfactant & Foaming Agents
5 API Stability Enhancers
5 Coloring Agents
4 Vegetarian Capsules

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 8 News #PharmaBuzz

1 Data Compilation #PharmaFlow
8 News #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 96 Regulatory FDF Prices, 6 Annual Reports

3 US Medicaid Prescriptions
96 Regulatory FDF Prices
6 Annual Reports

MARKET PLACE

6 APIs

6 APIs

PATENTS & EXCLUSIVITIES

20 Health Canada Patents

20 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 EDQM, 3 USP, 3 Others

4 EDQM
3 USP
3 Others

$ API Ref.Price (USD/KG) : 5,188 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Name Reset all filters

3 All

01 3USP

filter CAS Number Reset all filters

3 All

01 1193146-85-9

02 11953-04-4; 69353-21-5

03 1Blank

filter Details Reset all filters

3 All

01 3Material Origin- Chemical Synthesis; USMCA- No; KORUS- No

filter Country Reset all filters

3 All

01 3U.S.A

Capital Farma Galantamine Hydrobromide

Product Main Page

01

US Pharmacopeia

CPhI North America

USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

Contact Supplier

Contact Supplier

Digital Content

Galantamine Hydrobromide (200 mg)

CAS Number : 1953-04-4; 69353-21-5

Quantity Per Vial : 200

Sale Unit : mg

Price : $365.00

Details : Material Origin- Chemical Synthesis; USMCA- N...

Monograph :

Storage :

Code/Batch No : Catalog #1287755 / R036S0

Product Web Link

Digital Content

Corporate PDF

02

US Pharmacopeia

CPhI North America

USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

Contact Supplier

Contact Supplier

Digital Content

Galantamine Hydrobromide Racemic (15 mg)

CAS Number : 193146-85-9

Quantity Per Vial : 15

Sale Unit : mg

Price : $760.00

Details : Material Origin- Chemical Synthesis; USMCA- N...

Monograph :

Storage :

Code/Batch No : Catalog #1287766 / R10970

Product Web Link

Digital Content

Corporate PDF

03

US Pharmacopeia

CPhI North America

USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

Contact Supplier

Contact Supplier

Digital Content

Galantamine Hydrobromide Related CompoundsMix...

CAS Number :

Quantity Per Vial : 25

Sale Unit : mg

Price : $814.00

Details : Material Origin- Chemical Synthesis; USMCA- N...

Monograph :

Storage :

Code/Batch No : Catalog #1287777 / R076X0

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!